CAS 53984-36-4
:Benzoic acid, 3-chloro-5-hydroxy-
- 3-Chloro-5-hydroxybenzoicacid
- 3-Hydroxy-5-chlorobenzoic acid
3-Chloro-5-hydroxybenzoic Acid
CAS:Formula:C7H5ClO3Purity:>98.0%(GC)(T)Color and Shape:White to Orange to Green powder to crystalMolecular weight:172.56Benzoic acid, 3-chloro-5-hydroxy-
CAS:Formula:C7H5ClO3Purity:97%Color and Shape:SolidMolecular weight:172.56583-chloro-5-hydroxybenzoic Acid
CAS:3-chloro-5-hydroxybenzoic AcidPurity:≥95%Molecular weight:172.57g/mol3-Chloro-5-hydroxybenzoic acid
CAS:3-Chloro-5-hydroxybenzoic acidPurity:95%Molecular weight:172.57g/mol3-chloro-5-hydroxybenzoic Acid
CAS:3-chloro-5-hydroxy Benzoic Acid (3-chloro-5-hydroxy BA) is an agonist of GPR81 (EC50 : 16 μM)Formula:C7H5ClO3Purity:98%Color and Shape:SolidMolecular weight:172.573-Chloro-5-hydroxybenzoic acid
CAS:3-Chloro-5-hydroxybenzoic acid is a fluorescent compound that has been used to study insulin resistance in rats. Using fluorescence resonance energy transfer, this study found that 3-chloro-5-hydroxybenzoic acid increases insulin sensitivity and decreases blood pressure levels. It is hypothesized that the observed effects are due to an increase in the uptake of 3,5-dihydroxybenzoic acid into cells, which helps regulate the release of nitric oxide from afferent arterioles. Increased nitric oxide leads to vasodilation and increased uptake of glucose by muscle cells. This mechanism may be responsible for the observed decrease in blood pressure and improved insulin sensitivity.
Formula:C7H5ClO3Purity:Min. 95%Color and Shape:PowderMolecular weight:172.56 g/mol3-Chloro-5-hydroxybenzoic acid
CAS:Formula:C7H5ClO3Purity:97%Color and Shape:SolidMolecular weight:172.565-Chloro-m-salicylic Acid
CAS:Controlled ProductApplications 5-Chloro-m-salicylic Acid was studied as a potential selective lactate receptor (GPR81) agonists with antilipolytic effects.
References Dvorak, C.A., et al.: ACS. Med. Chem. Lett., 3, 637 (2012);Formula:C7H5ClO3Color and Shape:NeatMolecular weight:172.57






